70 related articles for article (PubMed ID: 23999041)
1. Synthesis and study of benzothiazole conjugates in the control of cell proliferation by modulating Ras/MEK/ERK-dependent pathway in MCF-7 cells.
Kamal A; Faazil S; Ramaiah MJ; Ashraf M; Balakrishna M; Pushpavalli SN; Patel N; Pal-Bhadra M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5733-9. PubMed ID: 23999041
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer evaluation of novel triazole linked N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine derivatives as inhibitors of cell survival proteins and inducers of apoptosis in MCF-7 breast cancer cells.
Kumbhare RM; Dadmal TL; Ramaiah MJ; Kishore KS; Pushpa Valli SN; Tiwari SK; Appalanaidu K; Rao YK; Bhadra MP
Bioorg Med Chem Lett; 2015 Feb; 25(3):654-8. PubMed ID: 25563891
[TBL] [Abstract][Full Text] [Related]
3. 2'-Nitroflavone induces apoptosis and modulates mitogen-activated protein kinase pathways in human leukaemia cells.
Cárdenas MG; Blank VC; Marder MN; Roguin LP
Anticancer Drugs; 2012 Sep; 23(8):815-26. PubMed ID: 22555195
[TBL] [Abstract][Full Text] [Related]
4. Quinazolino linked 4β-amidopodophyllotoxin conjugates regulate angiogenic pathway and control breast cancer cell proliferation.
Kamal A; Tamboli JR; Ramaiah MJ; Adil SF; Pushpavalli SN; Ganesh R; Sarma P; Bhadra U; Pal-Bhadra M
Bioorg Med Chem; 2013 Nov; 21(21):6414-26. PubMed ID: 24055291
[TBL] [Abstract][Full Text] [Related]
5. Differential anti-tumor activities of curcumin against Ras- and Src-activated human adenocarcinoma cells.
Ono M; Higuchi T; Takeshima M; Chen C; Nakano S
Biochem Biophys Res Commun; 2013 Jun; 436(2):186-91. PubMed ID: 23726918
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
Ding SZ; Smith MF; Goldberg JB
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
8. Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.
Park SS; Park SK; Lim JH; Choi YH; Kim WJ; Moon SK
Oncol Rep; 2011 Jan; 25(1):223-30. PubMed ID: 21109980
[TBL] [Abstract][Full Text] [Related]
9. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
10. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
11. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
12. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
[TBL] [Abstract][Full Text] [Related]
13. CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells.
Chen TJ; Gao F; Yang T; Thakur A; Ren H; Li Y; Zhang S; Wang T; Chen MW
Biochem Biophys Res Commun; 2013 Jul; 437(1):108-13. PubMed ID: 23806693
[TBL] [Abstract][Full Text] [Related]
14. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.
Riuzzi F; Sorci G; Donato R
J Cell Physiol; 2006 May; 207(2):461-70. PubMed ID: 16419039
[TBL] [Abstract][Full Text] [Related]
15. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
16. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
17. Cadmium-induced hormetic effect in differentiated Caco-2 cells: ERK and p38 activation without cell proliferation stimulation.
Mantha M; Jumarie C
J Cell Physiol; 2010 Jul; 224(1):250-61. PubMed ID: 20232314
[TBL] [Abstract][Full Text] [Related]
18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
19. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of pyrazolo[1,5-a]pyrimidine linked aminobenzothiazole conjugates as potential anticancer agents.
Kamal A; Tamboli JR; Nayak VL; Adil SF; Vishnuvardhan MV; Ramakrishna S
Bioorg Med Chem Lett; 2013 Jun; 23(11):3208-15. PubMed ID: 23623491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
